Alma Harmony XL PRO

Alma Harmony XL PRO

Alma Harmony XL PRO

Energy-based aesthetic medical device (multi-application laser and light platform)
  • CE Marked medical device used in the EU/EEA for aesthetic and dermatologic laser and light Based treatments; clinic and distributor descriptions explicitly reference CE certification for Harmony XL PRO.
  • Registered as a medical device with at least one European national authority (e.g. Estonian medical device database entry listing Harmony XL Pro as a medical device, risk class IIb, for multi Functional laser treatment of skin problems requiring aesthetic medical intervention).
  • Multiple clinic sites and marketing materials state that Harmony XL PRO is both CE Certified and FDA Cleared for numerous aesthetic indications.
  • The platform and its handpieces have received multiple U.S. FDA 510(k) clearances under device product code GEX (laser surgical instrument for use in dermatology and plastic surgery) for indications such as skin resurfacing, treatment of vascular and pigmented lesions and tattoo removal; FDA databases list Harmony XL PRO devices manufactured by Alma Lasers Ltd, Caesarea, Israel, with cleared 510(k) submissions (e.g. K072564 and subsequent updates) and related MAUDE adverse event reports.
  • Clinic and supplier information describes Harmony XL PRO as operating with FDA and CE Cleared technologies and being used worldwide in many countries including the UK, EU member states, North America and Asia.
  • Alma Lasers Ltd. states that it develops laser, light Based, radiofrequency, plasma and ultrasound devices for the aesthetic and surgical markets and operates under quality systems consistent with medical device regulatory requirements; Harmony XL PRO is part of this regulated portfolio.
Medical-grade multi-application laser, IPL and near-infrared platform for dermatologic and aesthetic skin treatments

Description

Alma Harmony XL PRO is a modular, multi-application aesthetic and dermatologic platform that combines multiple laser, intense pulsed light (IPL) and near-infrared (NIR) technologies in a single medical-grade system. It is designed to deliver ablative and non-ablative treatments for a wide range of indications including skin resurfacing and texture, skin remodelling and lifting, vascular lesions, pigmented lesions, tattoos, hair removal, acne and acne scars, using dedicated handpieces such as ClearLift (Q-switch Nd:YAG), ClearSkin Pro (1540 nm Er:Glass), iPixel (2940 nm Er:YAG), LP Nd:YAG, Dye-VL / Dye-SR and various AFT IPL applicators. The specific unit referenced in the context is a used Alma Harmony XL PRO system manufactured in December 2018 (labelled 12.2018) and advertised as approximately five years old at the time of listing, in full working order with minimal use over the preceding twelve months and supplied with multiple handpieces and a Zimmer 5 cooler.

Bnefits

  • Multi-application platform allowing one console to deliver multiple aesthetic and dermatologic treatments including skin resurfacing, skin remodelling and lifting, vascular and pigmented lesion treatment, hair removal, acne and acne scar treatment, and tattoo removal.
  • Combines several energy-based technologies in one system, including Q-switch Nd:YAG lasers, Er:YAG and Er:Glass fractional lasers, long-pulse Nd:YAG, narrow-band and broadband AFT IPL, and near-infrared (NIR) light for non-invasive skin tightening.
  • FDA-cleared for a large number of aesthetic and medical indications (often cited as over 65 or more indications) and CE-certified as a medical device, supporting use in many international markets.
  • Upgradeable and modular platform architecture, enabling clinics to add or change handpieces and technologies as clinical and business needs evolve without replacing the entire system.
  • Treats a broad range of skin types (commonly I–VI, depending on applicator and indication) and body areas, with options for fractional and non-fractional approaches and variable downtime profiles.
  • Supports combination and sequential treatments (e.g. combining fractional resurfacing with vascular or pigment-targeting modules) to tailor protocols and offer holistic treatment plans.
  • Well-established clinical use with multiple handpieces (e.g. ClearLift Q-switch, ClearSkin acne laser, Dye-VL vascular/pigment IPL) described in clinical literature and manufacturer resources.
  • The referenced used system comes with a comprehensive set of applicators (including LP Nd:YAG, Dye VL, ClearLift, Er:YAG, ClearSkin, SR and NIR) and a Zimmer 5 cooler, enabling a wide treatment portfolio from a single device.

Indications

  • Skin resurfacing, texture and tone improvement, including fractional ablative and non-ablative resurfacing (e.g. iPixel Er:YAG, ClearLift fractional Q-switch).
  • Skin remodelling and lifting, including non-invasive tightening and collagen stimulation with NIR and fractional laser modes.
  • Treatment of vascular lesions such as facial telangiectasia, spider veins, broken capillaries and other superficial vascular changes (using LP Nd:YAG, Dye-VL/Dye-SR and related applicators).
  • Treatment of pigmented lesions and dyschromia, including sun damage, hyperpigmentation, lentigines, and other benign epidermal and dermal pigmented lesions (Q-switch Nd:YAG and Dye-VL/Dye-SR).
  • Tattoo removal, including multi-colour tattoos using Q-switch Nd:YAG with 1064 nm and 532 nm wavelengths and fractional scanning options.
  • Hair removal and hair reduction using AFT IPL-based hair removal applicators (e.g. Speed AFT) and SHR technology on appropriate skin and hair types.
  • Treatment of active acne and acne scars (e.g. ClearSkin / ClearSkin Pro Er:Glass 1540 nm non-ablative laser with vacuum and cooling).
  • Treatment of scars and stretch marks/striae (fractional ablative and non-ablative modes).
  • Non-surgical skin rejuvenation and photorejuvenation of the face and body, including reduction of fine lines, wrinkles and overall photoaging signs.
  • Clinic and manufacturer materials also describe use for selected nail fungus, some birthmarks, cellulite appearance, and specific lesion types depending on handpiece and protocol.

Composition

  • Not a medicinal product – this is a capital medical device consisting of an electronic laser and light-based console and interchangeable handpieces, not a pharmaceutical formulation.
  • Console: Harmony XL PRO main unit housing power supply, control electronics, touch-screen user interface, cooling system (water circuit with pump, reservoir, dual-fan radiator, filters and sensors), and connectors for modular applicators.
  • Handpieces / applicators (selection, depending on configuration): ClearLift Q-switch Nd:YAG (1064 nm, 532 nm) fractional and non-fractional; ClearSkin / ClearSkin Pro non-ablative Er:Glass 1540 nm laser with vacuum and contact cooling; iPixel Er:YAG 2940 nm fractional ablative laser; long-pulse Nd:YAG 1064 nm applicator; Dye-VL and Dye-SR narrow-band IPL applicators; Speed AFT hair removal IPL; VL/PL 540 cooled IPL; NIR face/body near-infrared applicators.
  • Typical electrical and optical parameters (model dependent): mains supply around 230 V, 50–60 Hz; laser wavelengths including 1064 nm, 532 nm, 1540 nm, 2940 nm plus IPL spectra in defined bands; pulse durations and repetition rates specific to each module (as detailed in technical specifications and manuals).
  • The used Alma Harmony XL PRO system referenced in the context is labelled with CE marking and electrical ratings of 230 V, 50–60 Hz, 10 A on the rear identification plate, and manufactured 12.2018 (serial number HXP01705) as shown on the device label image.

Formulation

  • Medical device form: modular, floor-standing laser and light-based platform with wheeled console and detachable handpieces; not a drug or topical formulation.
  • Energy sources integrated via modules: Q-switch Nd:YAG laser (1064 nm and 532 nm), Er:YAG 2940 nm laser, Er:Glass 1540 nm laser, long-pulse Nd:YAG 1064 nm laser, broadband and narrow-band AFT IPL sources, and high-power NIR light sources, depending on configuration.
  • Each applicator module contains the optical train, treatment tip and cooling interfaces, connected to the console via an umbilical cable carrying power, control signals and cooling fluid.
  • System software recognises attached modules and provides pre-set treatment parameters and ranges based on indication and skin type, with operator-adjustable fluence, pulse duration, repetition rate and cooling within defined safety limits.
  • The platform is designed as a non-invasive or minimally invasive system for dermatologic and aesthetic treatments using selective photothermolysis, fractional photothermolysis and controlled dermal heating mechanisms.

Packaging

  • Primary configuration: Harmony XL PRO console (floor-standing unit with integrated display and controls) plus selected applicator handpieces and their associated cables and tips, as specified in the system configuration when purchased new.
  • The used system described in the context is advertised with the following handpieces and shot counts: LP Nd:YAG (~49,077 shots); Dye VL (~132,254); ClearLift handpiece (~244,397 shots) plus a second ClearLift handpiece (~1,480,672 shots); Er:YAG (~21,538); ClearSkin (~36,993); SR (~3,895); NIR (no pulse counter as it uses continuous heat), together with a Zimmer 5 cooler, manuals and protective eyewear.
  • Physical packaging for shipment typically includes the console and handpieces secured in crates or padded transport packaging, with accessories such as footswitch, power cables, eyewear and documentation; exact packaging format varies by seller (new vs used) and is not fully specified publicly.
  • Labelling on the device includes product name (Harmony XL PRO), serial number, manufacturing date (e.g. 12.2018 for the referenced system), electrical ratings, CE marking and Alma Lasers contact details, as visible on the rear label image.

Usage

  • Harmony XL PRO is a prescription-use medical laser and light platform intended only for operation by appropriately trained and qualified healthcare professionals or laser practitioners, in accordance with local regulations and Alma’s operator manuals.
  • Before use, the operator should select the appropriate applicator (e.g. ClearLift, ClearSkin, iPixel, LP Nd:YAG, Dye-VL, hair removal AFT, NIR) based on the indication, skin type and treatment area, connect it to the console, and confirm recognition and readiness via the system interface.
  • Standard pre-treatment steps in clinic protocols include: consultation and medical history, assessment of skin type and indication, discussion of expected outcomes and side effects, obtaining informed consent, cleansing the treatment area, removal of makeup, shaving hair where relevant, and donning appropriate eye protection for both patient and operator.
  • Treatment parameters (fluence, pulse duration, repetition rate, number of passes, cooling level) are chosen using manufacturer guidelines and clinical judgment, taking into account skin type (Fitzpatrick) and indication; Alma’s platform provides presets and tutorials but final responsibility rests with the practitioner.
  • During treatment, the handpiece is applied to the skin with appropriate coupling (contact, slight pressure or distance depending on applicator). IPL and laser shots are delivered in systematic passes over the treatment area. Cooling (contact, air or Zimmer 5 cooler as in the referenced used system) may be used to increase comfort and reduce thermal injury risk.
  • After treatment, common instructions from clinics using Harmony XL PRO include avoiding direct sun exposure, using broad-spectrum sunscreen, not picking at crusts or peeling skin, following skin-care recommendations (e.g. gentle cleansers, moisturisers) and monitoring for any unusual or prolonged reactions.
  • Treatment protocols vary by indication: for example, fractional resurfacing (iPixel) may be performed in 1–3 sessions spaced several weeks apart, with visible grid-pattern frosting and more downtime; ClearLift ‘lunchtime’ rejuvenation is often promoted as having minimal downtime with multiple sessions; NIR skin tightening protocols may involve 6–8 sessions every 2–3 weeks; ClearSkin acne protocols often use repeated sessions every 2–4 weeks.
  • Operators should follow safety guidelines including appropriate room signage, controlled access to the laser room, use of wavelength-appropriate eye protection, adherence to manufacturer maintenance schedules, and compliance with national laser safety standards.
  • Specific operating instructions, parameter tables and safety precautions are provided in Alma Harmony XL PRO operator and service manuals and must be followed; these documents are not fully publicly available and require authorised access.

Contraindications

  • Not a medicinal product – contraindications relate to energy-based laser and light procedures rather than drug administration.
  • Commonly listed contraindications for Harmony XL PRO laser/IPL treatments in clinic protocols include: pregnancy and breastfeeding.
  • Inflammation, infection or active disease in the planned treatment area (e.g. active dermatitis, open wounds, local skin infections).
  • History of or current malignant disease (cancer) in the treatment area, or serious systemic malignancy, depending on protocol.
  • Tendency to form keloid or hypertrophic scars, or other significant scarring disorders.
  • Active psoriasis or other significant active inflammatory dermatoses in the treatment area, depending on the indication.
  • Severe renal insufficiency or serious systemic illness may be cited as contraindications in some clinic protocols for laser treatments.
  • History of epilepsy or seizure disorders, especially photosensitive epilepsy, is often treated as a contraindication or requires caution for intense light-based treatments.
  • Use of photosensitising medications (e.g. certain antibiotics, isotretinoin within a specified past period, some diuretics such as hydrochlorothiazide) or other agents that significantly increase light sensitivity.
  • Recent strong sun exposure, tanning (natural or artificial) or use of self-tanning products in the treatment area that increases the risk of burns and pigmentary changes.
  • Presence of implanted electronic medical devices near the treatment area (for some applicators) may require caution or represent a contraindication as per device manuals.
  • Exact contraindications, including time limits after isotretinoin and other specific drugs, must be taken from the official Alma Harmony XL PRO instructions for use and local clinical guidelines; these full lists are not fully publicly available.

Adverse Effects

  • Not a medicinal product – adverse effects relate to laser and light-based procedures delivered by the Harmony XL PRO platform, rather than drug side effects.
  • Frequently reported, generally mild and transient side effects after Harmony XL PRO treatments (across multiple applicators) include: erythema (redness), oedema (swelling), a warm or sunburn-like sensation, skin tightness, mild discomfort during and shortly after treatment, and temporary darkening of pigmented lesions before they lighten.
  • For fractional resurfacing procedures such as iPixel Er:YAG, expected effects described by clinics include visible grid-like frosting or patterning on the skin, more pronounced redness and swelling, a sunburn sensation for hours, and peeling or flaking over several days as microscopic treatment zones heal.
  • After vascular or pigment IPL treatments (e.g. DYE-VL / DYE-SR), commonly mentioned reactions include transient redness, swelling, darkening of pigmented lesions, occasional crusting, and rare blistering; these usually resolve over days when appropriate aftercare is followed.
  • For ClearLift Q-switch fractional treatments, clinics report that side effects are typically minimal, but mild swelling or redness can occur and may last from a few hours up to about 24 hours; very occasionally small blisters or longer-lasting redness may be observed.
  • For ClearSkin acne treatments, temporary redness and mild swelling are commonly mentioned, with most patients able to resume normal activities immediately; thermal discomfort is usually described as mild and manageable.
  • NIR skin tightening protocols describe mild, transient redness or swelling and a warm sensation during and shortly after treatment, generally resolving within hours to a day.
  • More significant but less common adverse events reported in clinical practice with high-intensity laser and IPL systems, and specifically noted in regulatory adverse event databases for Harmony XL PRO, include burns, blistering, post-inflammatory hyperpigmentation, scarring and persistent pigmentary changes.
  • FDA MAUDE adverse event reports for Alma Harmony XL PRO devices describe events such as burns with subsequent scar formation on the cheek and burns associated with post-inflammatory hyperpigmentation following Harmony XL PRO long-pulse hair removal treatments; in these reports, contributory factors such as photosensitising medications were sometimes noted.
  • Serious complications are considered rare when Harmony XL PRO is used by appropriately trained personnel following Alma’s instructions and local laser safety standards, but patients should be counselled about risks of burns, pigmentary changes, scarring, infection and eye injury if safety measures are not followed.

Storage Conditions

  • Not publicly listed in detail for all models; Alma’s full environmental storage and transportation conditions (e.g. allowable temperature and humidity ranges, shock and vibration limits) are specified in internal technical and operator manuals that are not fully available publicly.
  • General practice for such medical laser platforms is to store and operate the device in a clean, dry, well-ventilated clinical environment, protected from excessive dust, moisture, and temperature extremes, with adequate electrical supply (e.g. 230 V, 50–60 Hz as shown on the device label of the referenced system) and regular maintenance of the internal water-cooling system according to the manufacturer’s instructions.
  • The device should be protected from impact during transport, secured against tipping, and maintained only by authorised engineers; detailed instructions are provided in Alma Harmony XL PRO manuals rather than general public sources.

Duration

Harmony XL PRO is used in repeated treatment sessions whose number and spacing depend on the indication, protocol and applicator. Clinic protocols commonly describe: fractional resurfacing/texture treatments (e.g. iPixel) in series of 1\u20133 or more sessions spaced several weeks apart; NIR skin tightening protocols of approximately 6\u20138 sessions at intervals of about 2\u20133 weeks with effects lasting up to roughly 12 months before maintenance; ClearSkin acne treatments performed in series (e.g. several sessions 2\u20133 weeks apart) with visible improvement over weeks to months; tattoo removal requiring multiple sessions spaced several weeks apart. A single treatment session can last from around 15\u201360 minutes depending on area and combination of modules. Exact treatment duration regimes are not fully standardised publicly and must follow manufacturer guidance and clinical judgment.

Onset

Onset of effect varies by indication and applicator. Clinic descriptions for Harmony XL PRO treatments report that for many vascular and pigment procedures (e.g. DYE-VL photofacials or spider vein treatments) initial improvement and vessel or pigment changes may be visible after the first session, with progressive results over subsequent treatments; ClearSkin acne treatments often show noticeable improvement in active acne within approximately 2\u20134 weeks and further texture improvement over several months; NIR skin tightening protocols describe an immediate tightening sensation and visible subtle lifting with ongoing collagen remodelling and further visible changes over weeks. Because this is a multi-technology platform, there is no single quantified onset-of-effect time for all indications in publicly available manufacturer or regulatory documents.

Browse more Energy-based aesthetic medical device (multi-application laser and light platform)

Top Treatments

Top Cities in the UK